1. Home
  2. AADI vs SELF Comparison

AADI vs SELF Comparison

Compare AADI & SELF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • SELF
  • Stock Information
  • Founded
  • AADI 2011
  • SELF 1983
  • Country
  • AADI United States
  • SELF United States
  • Employees
  • AADI N/A
  • SELF N/A
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • SELF Real Estate Investment Trusts
  • Sector
  • AADI Health Care
  • SELF Real Estate
  • Exchange
  • AADI Nasdaq
  • SELF Nasdaq
  • Market Cap
  • AADI 49.0M
  • SELF 57.5M
  • IPO Year
  • AADI N/A
  • SELF N/A
  • Fundamental
  • Price
  • AADI $2.11
  • SELF $5.13
  • Analyst Decision
  • AADI Hold
  • SELF
  • Analyst Count
  • AADI 3
  • SELF 0
  • Target Price
  • AADI $1.75
  • SELF N/A
  • AVG Volume (30 Days)
  • AADI 114.7K
  • SELF 13.1K
  • Earning Date
  • AADI 11-06-2024
  • SELF 11-08-2024
  • Dividend Yield
  • AADI N/A
  • SELF 5.68%
  • EPS Growth
  • AADI N/A
  • SELF 39.82
  • EPS
  • AADI N/A
  • SELF 0.28
  • Revenue
  • AADI $25,070,000.00
  • SELF $12,319,724.00
  • Revenue This Year
  • AADI $8.10
  • SELF N/A
  • Revenue Next Year
  • AADI $8.54
  • SELF N/A
  • P/E Ratio
  • AADI N/A
  • SELF $18.36
  • Revenue Growth
  • AADI 7.80
  • SELF 0.38
  • 52 Week Low
  • AADI $1.21
  • SELF $4.01
  • 52 Week High
  • AADI $5.70
  • SELF $5.85
  • Technical
  • Relative Strength Index (RSI)
  • AADI 56.23
  • SELF 53.20
  • Support Level
  • AADI $1.98
  • SELF $5.10
  • Resistance Level
  • AADI $2.40
  • SELF $5.29
  • Average True Range (ATR)
  • AADI 0.11
  • SELF 0.15
  • MACD
  • AADI 0.01
  • SELF 0.02
  • Stochastic Oscillator
  • AADI 36.96
  • SELF 57.89

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About SELF Global Self Storage Inc.

Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to 13 self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.

Share on Social Networks: